Clinical trial

An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases

NCT07236762

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2025-11-24

PhasePHASE1

Study timeline

Study start (actual)2025-11-24Date precision: day

Registry last updated2026-03-04

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Systemic Lupus Erythematosusunresolved

Lupus Nephritis (LN)unresolved

Sjogren's Syndromeunresolved

Inflammatory Myopathyunresolved

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitisunresolved

Antiphospholipid Syndromeunresolved

Interventions

YTS109 cellDRUG

Sponsors & collaborators

China Immunotech (Beijing) Biotechnology Co., Ltd.lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07236762 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.